Product image of Nebivololo Alter (Nebivolol Hydrochloride) supplied by GNH India

Nebivololo Alter

Active Ingredient:
Nebivolol Hydrochloride
Origin:
EU

Nebivololo Alter (Nebivolol Hydrochloride)

Nebivolol, the active ingredient in Nebivolo Alter, is a beta blocker presented as an oral tablet for oral use. It lowers elevated blood pressure and is indicated for treatment of hypertension in adult patients, primarily those with primary hypertension and may be used as part of combination therapy.

GNH India supplies Nebivolo Alter as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, adhering to EU quality standards and providing reliable bulk shipments. The company ensures compliance with Good Distribution Practice, offers temperature‑controlled logistics where required, and supports regulatory documentation for international markets.

Manufacturer / TM Owner

Laboratori Alter S.R.L.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Nebivolol is a beta‑adrenergic blocker used in the management of cardiovascular conditions, primarily hypertension.
  • Hypertension: reduces systolic and diastolic blood pressure in patients with primary hypertension.
  • Heart failure with reduced ejection fraction: improves cardiac output and symptoms in chronic heart failure patients.
  • Ischemic heart disease (off‑label): may be used to lower myocardial oxygen demand in selected cases.

How It Works

  • Nebivolol selectively antagonizes β1‑adrenergic receptors, decreasing heart rate and myocardial contractility, which lowers cardiac output. In addition, it stimulates endothelial nitric‑oxide synthase, leading to nitric‑oxide mediated vasodilation and further reduction of peripheral vascular resistance, contributing to its antihypertensive effect.

Side Effects

Nebivolol may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects

  • Headache: mild to moderate headache reported during initiation.
  • Dizziness or light‑headedness: due to blood pressure lowering.
  • Fatigue or tiredness: often transient.
  • Nausea: occasional gastrointestinal upset.
  • Bradycardia: slower heart rate, usually asymptomatic.
  • Peripheral edema: mild swelling of lower limbs.

Serious or Rare Side Effects

  • Severe bradycardia: markedly low heart rate requiring medical attention.
  • Symptomatic hypotension: sudden drop in blood pressure causing faintness.
  • Bronchospasm: especially in patients with asthma or COPD.
  • Allergic reactions: rash, pruritus, or angioedema.
  • Hepatic injury: abnormal liver enzymes.
  • Cardiac conduction disturbances: AV block or heart block.

Precautions & Warnings

  • Before prescribing Nebivolol, clinicians should consider several safety aspects.
  • Monitor blood pressure: ensure adequate control without excessive drop.
  • Assess heart rate: watch for bradycardia, especially in patients with pre‑existing low rates.
  • Caution in asthma or COPD: β1‑selectivity may still affect bronchial tone.
  • Avoid abrupt discontinuation: taper to prevent rebound hypertension.
  • Renal or hepatic impairment: dose adjustment may be necessary.
  • Store at ambient temperature: keep in the original pack, protect from moisture.

Avoid Interactions

Nebivolol can interact with other medicines, influencing its safety and efficacy.

Major Interactions (Avoid)

  • Combined use with other beta blockers: risk of excessive bradycardia and hypotension.
  • Concomitant calcium channel blockers (verapamil, diltiazem): may cause severe AV block.
  • Non‑selective beta antagonists in asthmatic patients: heightened risk of bronchospasm.

Moderate Interactions (Monitor Closely):\n- ACE inhibitors or ARBs: additive hypotensive effect, monitor blood pressure.

  • Diuretics: may enhance antihypertensive response, watch for electrolyte changes.
  • Certain antidepressants (e.g., SSRIs): may affect nebivolol metabolism, adjust monitoring.

Frequently Asked Questions

Nebivolo Alter contains nebivolol, a beta‑blocker indicated for the treatment of primary hypertension in adult patients. It may also be prescribed for chronic heart failure with reduced ejection fraction, helping to improve cardiac function and control blood pressure.

Nebivolol selectively blocks β1‑adrenergic receptors, reducing heart rate and contractility, which lowers cardiac output. It also enhances nitric‑oxide release from the endothelium, causing vasodilation and decreasing peripheral vascular resistance, together resulting in lowered blood pressure.

The appropriate dose of Nebivolo Alter is determined by the prescribing clinician based on the patient’s clinical condition, response to therapy, and any co‑existing medical issues. Dosage adjustments are made individually and should follow the prescriber’s instructions.

The safety of nebivolol in pregnancy and lactation has not been definitively established. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and the decision must be made by a qualified healthcare professional.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Nebivolol is a β1‑selective blocker with additional nitric‑oxide mediated vasodilation, which can offer better tolerability regarding metabolic effects compared with non‑selective beta‑blockers. Compared with ACE inhibitors or calcium‑channel blockers, it provides a distinct mechanism and may be preferred in patients who benefit from heart‑rate reduction.

Nebivolo Alter should be stored at ambient temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and avoid storing it in bathrooms or other humid environments.

Nebivolo Alter is taken orally, usually once daily, with or without food, as directed by the prescribing physician. The tablet should be swallowed whole with a glass of water and not chewed or crushed unless specifically instructed.

Serious risks include severe bradycardia, symptomatic hypotension, bronchospasm in patients with reactive airway disease, and rare cases of hepatic injury or cardiac conduction disturbances such as AV block. Patients should be monitored for these events, especially during treatment initiation or dose changes.

Nebivolo Alter is contraindicated in patients with known hypersensitivity to nebivolol or any component of the formulation, in those with severe bradycardia, second‑ or third‑degree AV block without a pacemaker, and in individuals with uncompensated heart failure or severe asthma/COPD where β‑blockade could worsen airway obstruction.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Nebivolol Hydrochloride

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT